Orthofix Medical Inc (OFIX) Stock AnalysisOFIXStock AnalysisOrthofix Medical Inc

Orthofix Medical Inc. is a global medical technology company. It offers a comprehensive portfolio of spinal hardware, bone growth therapies, limb reconstruction solutions, biologics and enabling technologies, including the 7D FLASH Navigation System. Its Global Spine segment offers two primary product categories: bone growth therapies and spinal implants, biologics, and enabling technologies. It provides implantable medical devices, biologics, enabling technologies, and other regenerative solutions which aim to restore the quality of life of patients suffering from diseases and traumas of the spine. It offers a variety of treatment solutions that incorporate multiple treatment modalities, such as mechanical, biological, and electromagnetic modes. Its Global Limb Reconstruction segment offers products and solutions for the underserved limb reconstruction market that encompasses four pillars: deformity correction, limb lengthening, complex fracture management, and limb preservation. It operates in the Healthcare sector (SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry).

Orthofix Medical Inc is currently trading at $9.70, which is significantly below the lowest analyst price target of $13, indicating potential upside. However, the stock has a low RSI of 34.59, suggesting it is oversold, but the recent 5-day change is down 3.10%, indicating continued weakness. The company has reduced its revenue guidance for 2026 to $845M-$855M, which is below the consensus of $843.31M, reflecting cautious market conditions. The main risk is the forward P/E ratio of 500, indicating potential overvaluation if earnings do not improve significantly in the near future.

7 analysts cover OFIX: 6 rate it Buy, 1 Hold and 0 Sell. The average price target is 21.33.